Ligand to Report Fourth Quarter Financial Results on February 22
Go back to Ligand to Report Fourth Quarter Financial Results on February 22| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 280.18 -6.11 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $286.29 | 52 Week High | $139.79 | |||
| Open | $286.27 | 52 Week Low | $82.07 | |||
| Day High | $286.27 | P/E | 651.58 | |||
| Day Low | $279.87 | EPS | $0.43 | |||
| Volume | 158,236 | |||||

